Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation
Acta Biomaterialia · 2024-06 · 181 · 402-414
DOI: 10.1016/j.actbio.2024.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-06. Verfasst von Siyuan Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang-Mauritius Joint Research Center for Biomaterials and Tissue Engineering, Institute of Smart Biomedical Materials, School of Materials Scienc…. Hauptthemen laut MEDLINE: Immunotherapy, Tumor Microenvironment. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Tumor hypoxia, high oxidative stress, and low immunogenic create a deep-rooted immunosuppressive microenvironment, posing a major challenge to the therapeutic efficiency of cancer immunotherapy for solid tumor. Herein, an intelligent nanoplatform responsive to the tumor microenvironment (TME) capable of hypoxia relief and immune stimulation has been engineered for efficient solid tumor immunotherapy. The MnO2@OxA@OMV nanoreactor, enclosing bacterial-derived outer membrane vesicles (OMVs)-wrapped MnO2 nanoenzyme and the immunogenic cell death inducer oxaliplatin (OxA), demonstrated intrinsic catalase-like activity within the TME, which effectively catalyzed the endogenous H2O2 into O2 to enable a prolonged oxygen supply, thereby alleviating the tumor's oxidative stress and hypoxic TME, and expediting OxA release. The combinational action of OxA-caused ICD effect and Mn2+ from nanoreactor enabled the motivation of the cGAS-STING pathway to significantly improve the activation of STING and dendritic cells (DCs) maturation, resulting in metalloimmunotherapy. Furthermore, the immunostimulant OMVs played a crucial role in promoting the infiltration of activated CD8+T cells into the solid tumor. Overall, the nanoreactor offers a robust platform for solid tumor treatment, highlighting the significant potential of combining relief from tumor hypoxia and immune stimulation for metalloimmunotherapy. STATEMENT OF SIGNIFICANCE: A tailor-made nanoreactor was fabricated by enclosing bacterial-derived outer membrane vesicles (OMVs) onto MnO2 nanoenzyme and loading with immunogenic cell death inducer oxaliplatin (OxA) for tumor metalloimmunotherapy. The nanoreactor possesses intrinsic catalase-like activity within the tumor microenvironment, which effectively enabled a prolonged oxygen supply by catalyzing the conversion of endogenous H2O2 into O2, thereby alleviating tumor hypoxia and expediting OxA release. Furthermore, the TME-responsive release of nutritional Mn2+ sensitized the cGAS-STING pathway and collaborated with OxA-induced immunogenic cell death (ICD). Combing with immunostimulatory OMVs enhances the uptake of nanoreactors by DCs and promotes the infiltration of activated CD8+T cells. This nanoreactor offers a robust platform for solid tumor treatment, highlighting the significant potential of combining relief from tumor hypoxia and immune stimulation for metalloimmunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang-Mauritius Joint Research Center for Biomaterials and Tissue Engineering, Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, Chin…
- Institute of Regenerative and Reconstructive Medicine, Med-X Institute, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710049, China.
Förderung
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Luo, S., Yang, Y., Chen, L., Kannan, P. R., Yang, W., Zhang, Y., Zhao, R., Liu, X., Li, Y., & Kong, X. (2024). Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation. Acta Biomaterialia, 181, 402-414. https://doi.org/10.1016/j.actbio.2024.05.010
Vancouver
Luo S, Yang Y, Chen L, Kannan PR, Yang W, Zhang Y, et al. Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation. Acta Biomaterialia. 2024;181:402-414. doi:10.1016/j.actbio.2024.05.010
BibTeX
@article{Luo2024,
author = {Luo, Siyuan and Yang, Yueyan and Chen, Liuting and Kannan, Perumal Ramesh and Yang, Weili and Zhang, Yongjia and Zhao, Ruibo and Liu, Xiaoli and Li, Yao and Kong, Xiangdong},
title = {Outer membrane vesicle-wrapped manganese nanoreactor for augmenting cancer metalloimmunotherapy through hypoxia attenuation and immune stimulation},
journal = {Acta Biomaterialia},
year = {2024},
volume = {181},
pages = {402--414},
doi = {10.1016/j.actbio.2024.05.010}
}
EUVIMED